Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2023-01-19 Earnings Release
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
Earnings Release Classification · 100% confidence The document is an 'Ad hoc announcement pursuant to Art. 53 LR' released on January 19, 2023. It provides preliminary financial highlights for the full year 2022 (revenue achieved, EBITDA better than expected) and raises the communicated EBITDA target range for 2022. It also includes a forward-looking agenda mentioning the '2022 Full-Year Results' release date (March 23, 2023). This structure—announcing key results and operational updates outside of a scheduled quarterly or annual filing—is characteristic of an Earnings Release (ER). It is not the comprehensive 10-K, nor is it a transcript (CT) or a formal Audit Report (AR). Since it contains the key financial outcomes immediately, it fits the ER definition best, even though it precedes the full annual report. FY 2022
2023-01-19 English
Zur Rose-Gruppe: Umsatzziel 2022 erreicht, Ergebnis besser als erwartet
Earnings Release Classification · 100% confidence The document is explicitly titled "Ad hoc-Mitteilung gemäss Art. 53 KR" (Ad hoc announcement pursuant to Art. 53 KR) and is dated January 19, 2023. It provides preliminary, unaudited financial highlights for the full year 2022 ("Umsatzziel 2022 erreicht, Ergebnis besser als erwartet") and updates the EBITDA guidance for 2022. This format—a timely, brief announcement of key financial results before the full official report—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the Interim Report (IR), as it only covers the full year and is an initial release. It is also not a Report Publication Announcement (RPA) because it contains the actual results and analysis, not just a notice that a report will be published later (though it does mention the full report publication date of March 23, 2023). Therefore, ER is the most appropriate classification. FY 2022
2023-01-19 German
Zur Rose Group takes next step towards profitability and further reduces complexity in Germany
Regulatory Filings Classification · 91% confidence The document is a press release dated November 24, 2022, detailing a strategic decision by Zur Rose Group to close a logistics site (Eurapon Pharmahandel GmbH) in Germany as a step towards profitability. It includes contact information for Investor Relations and Media, and an agenda listing future events, including the '2022 Full-Year Results' and 'Annual General Meeting'. This content is a corporate announcement regarding strategic operational changes, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed management discussion (MDA). Since it announces a strategic business decision and is presented as a 'Press release' detailing operational restructuring, it fits best under the general category of corporate news that doesn't align with the more specific financial or governance codes. Given the options, it is a general corporate announcement. While it is not a perfect fit for any single category, 'RNS' (Regulatory Filings/General regulatory announcements and fallback category) is the most appropriate fallback for significant, non-standard corporate news that isn't explicitly covered by the other codes, especially since it is not a formal financial report itself.
2022-11-24 English
Zur Rose Group takes next step towards profitability and further reduces complexity in Germany
M&A Activity Classification · 99% confidence The document is a press release dated 24.11.2022 announcing a strategic decision by Zur Rose Group AG to close the Eurapon logistics site and discontinue the Eurapon brand in Germany as a step towards profitability. It details operational changes, employee considerations, and provides contact information and an agenda for future investor events (Sales 2022, Full-Year Results, AGM, etc.). This content is a corporate announcement regarding strategic restructuring and operational changes, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific report (AR, SR). Since it is a general corporate announcement that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory announcement fallback category, RNS, as it is a news release disseminated to the market.
2022-11-24 English
Zur Rose-Gruppe macht nächsten Schritt in Richtung Profitabilität und reduziert Komplexität in Deutschland weiter
M&A Activity Classification · 99% confidence The document is a short press release dated 24.11.2022 from Zur Rose Group AG, announcing a strategic decision to close the Eurapon Pharmahandel GmbH logistics site in Bremen and discontinue the Eurapon brand as part of a move towards profitability. It includes contact information, an agenda for future investor events (like 'Jahresergebnis 2022' and 'Ordentliche Generalversammlung'), and a company profile. Since this is an announcement about a strategic business decision (reducing complexity/restructuring) rather than a formal financial report (like 10-K or IR) or a specific regulatory filing like insider trading (DIRS) or dividend (DIV), it best fits the general category for corporate announcements that aren't covered by more specific codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news release that doesn't fit the other specific categories like ER, CT, or CAP. It is not a Report Publication Announcement (RPA) because it is announcing a business action, not the publication of a financial report.
2022-11-24 German
Procurement and supply chain brought together under the new Chief Operations Officer
Board/Management Information Classification · 100% confidence The document is explicitly labeled as an "Ad-hoc announcement pursuant to Art. 53 LR" and is released on November 1, 2022. The content details a significant internal organizational change: the appointment of a new Chief Operations Officer (COO), Kaspar Niklaus, and the restructuring of responsibilities (bringing procurement and supply chain together). This type of announcement, concerning key personnel changes in senior management, directly matches the definition for Board/Management Information (MANG). It is not a full annual report (10-K), an earnings release (ER), or a transcript (CT).
2022-11-01 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.